White & Case Advises Placing Agents on Hansa Biopharma's Directed Share Issue
April 20, 2024
April 20, 2024
NEW YORK, April 20 -- White and Case, a law firm, issued the following news release:
Global law firm White & Case LLP has advised William Blair & Company, L.L.C. and Carnegie Investment Bank AB on a directed share issue by Hansa Biopharma AB, a commercial-stage biopharmaceutical company that develops treatments for patients with rare immunological conditions.
The White & Case team which advised on the transaction was led by partner Rikard Stenberg (Stockholm . . .
Global law firm White & Case LLP has advised William Blair & Company, L.L.C. and Carnegie Investment Bank AB on a directed share issue by Hansa Biopharma AB, a commercial-stage biopharmaceutical company that develops treatments for patients with rare immunological conditions.
The White & Case team which advised on the transaction was led by partner Rikard Stenberg (Stockholm . . .